Clinical Trial

Feasibility and Acceptibility of a Multi-site Trial of Time Restircted Eating During Chemotheraply for Breast Cancer.

Recruiting
View on ClinicalTrials.gov →
Summary
This study is being done to better understand how time restricted eating (eating all food in an 8 hour window) can help a person receiving chemotherapy treatment for breast cancer, stages I-IV. The aim is to find out if time restricted is feasible and acceptable to individuals starting chemotherapy for breast cancer. We will test 3 different eating window options compared to a control group for 24 weeks.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-05-02
critical Phase changed: Phase 1 -> not applicable 2026-05-02
Trial Details
NCT Number NCT07387445
Lead Sponsor University of Illinois at Chicago
Conditions Breast Cancer Early Stage Breast Cancer (Stage 1-3), Breast Neoplasm Female, Breast Cancer
Enrollment 40 participants
Start Date 2026-02-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-01